Company: JUNS
Filing Date: 2025-10-28
Form Type: PRER14A
Source: 0001493152-25-019793
Chunk: 2

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-10-28
Form: PRER14A
Chunk 2
---
 OF JUPITER NEUROSCIENCES, INC.

To Be Held on December 19, 2025 at 10:00 A.M. Eastern Time</div>

To the Stockholders of Jupiter Neurosciences, Inc.:

The 2025 Annual Meeting of Stockholders (the “ Annual Meeting”) of Jupiter Neurosciences, Inc., a Delaware corporation (“ Jupiter,” the “ Company,” “ us,” “ our,” or “ we”), will be held in a virtual meeting format on December 19, 2025 at 10:00 a.m. Eastern Time. You may attend, vote and submit questions during the Annual Meeting via the Internet at https://meetings.lumiconnect.com/200-142-773-960. We have designed the format of the Annual Meeting to ensure that you are afforded the same rights and opportunities to participate as you would at an in-person meeting, using online tools to ensure your access and participation.

The purpose of the Annual Meeting is to consider and act upon the following matters:

1. To elect seven (7) directors, the names of whom are set forth in the accompanying Proxy Statement, each to serve until the 2026 annual meeting of stockholders and until their respective successors are duly elected and qualified;

2. To approve an amendment to the Company’s certificate of incorporation to increase the authorized shares of common stock, par value $0.0001 per share (the “ Common Stock”), available for issuance from 125,000,000 shares to 500,000,000 shares;

3. To approve the adoption of the Jupiter Neurosciences, Inc. 2025 Equity Incentive Plan;

4. To ratify the selection of Cherry Bekaert LLP (“ Cherry Bekaert”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025;

5. To approve, for purposes of complying
with Nasdaq Listing Rules 5635(b) and 5635(d), the potential issuance of shares of Common Stock in excess of 19.99% or more of the Company’s
issued and outstanding Common Stock of up to $20 million of securities pursuant to a Standby Equity Purchase Agreement (the “SEPA”)
with YA II PN, Ltd. (“Yorkville”), including upon conversion of convertible promissory notes issued to Yorkville in
connection with the SEPA;

and

6.To transact such other business as may properly be brought before the Annual Meeting and any adjournment or